Preventing Forced Abortions Act of 2026
Summary
HR9868 (Preventing Forced Abortions Act of 2026) is an early-stage bill that restricts federal court enforcement of surrogacy contract clauses requiring abortion, with no authorized funding or direct market exposure. The legislation has no material financial impact on any public company or sector.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9868 is a narrow surrogacy contract enforcement bill with zero authorized spending.
- 2.The bill is in early legislative stages and faces low probability of enactment.
- 3.No publicly traded companies have identifiable revenue exposure from this legislation.
Market Implications
This bill carries no market-moving potential. No companies are identified as beneficiaries or losers. Investors should focus on other legislative signals with actual funding or regulatory teeth.
Full Analysis
The Preventing Forced Abortions Act of 2026, introduced by Rep. Ogles (R-TN) on July 22, 2026, was referred to the House Judiciary Committee. Despite its title, the bill's actual text focuses exclusively on surrogacy contract enforcement: it prohibits federal courts from enforcing any term that requires a surrogate to have an abortion and mandates that courts uphold compensation clauses regardless of such provisions. It also grants federal district courts jurisdiction over surrogacy contract disputes in interstate commerce. No funding is authorized or appropriated. The bill is procedural and contractual in nature, with no mention of government spending, tax credits, grants, or procurement. As an early-stage bill with 7 cosponsors (all Republicans) and only committee referral, its passage probability is low in the current Congress. The legislation does not alter any federal program, create new regulatory burdens for corporations, or allocate taxpayer dollars. There are no publicly traded companies whose revenue streams, costs, or competitive positions are directly affected. Convergence with other signals is absent from the provided data. The sole affected sector is Healthcare due to the bill's tangential relation to reproductive health contracts, but the impact is negligible.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
PA DEPARTMENT OF HUMAN SERVICES: $1.0B Department of Health and Human Services Grant
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND): $1.8B Department of State Federal Award
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →